Loading organizations...
Tuesday Health delivers comprehensive supportive care for individuals facing serious illness. The organization offers an integrated solution encompassing symptom management, advance care planning, and emotional support. Its care model emphasizes accessibility, providing services through in-person visits, telehealth, and continuous availability, functioning as a value-based provider dedicated to whole-person care.
The company emerged in 2023 from a strategic partnership between Valtruis and Mass General Brigham Ventures. This collaboration was driven by the insight that individuals with serious illnesses require more compassionate, personalized, and needs-aligned care. Jim Wieland serves as the CEO, guiding the company's operational strategy and mission.
Tuesday Health primarily serves seriously ill patients and high-risk, high-cost members, extending its support to their caregivers as well. The company’s overarching vision is to transform the experience of serious illness by ensuring that patients and their families receive continuous, empathetic support tailored to their specific journeys, fostering a sense of dignity and well-being.
Tuesday Health has raised $60.0M across 1 funding round.
Tuesday Health has raised $60.0M in total across 1 funding round.
Tuesday Health has raised $60.0M across 1 funding round. Most recently, it raised $60.0M Series A in May 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| May 1, 2024 | $60M Series A | — | Bluecross Blueshield Venture Partners, David Caluori | Announced |
Tuesday Health is a value-based supportive care organization launched in 2023 that builds a technology-enabled platform combining clinical expertise, data analytics, and the mytuesday app to deliver personalized care for seriously ill patients and caregivers.[1][2][4] It serves high-risk Medicare, Medicare-Medicaid dual eligibles, and accountable care organization patients facing serious illnesses with 12-18 month prognoses, solving gaps in proactive symptom management, hospitalization reduction, and seamless transitions to hospice by offering hybrid in-home, telehealth, and app-based monitoring.[2][3][4] Backed by $60 million from investors like Valtruis, Blue Venture Fund, Mass General Brigham Ventures, and CareSource, the company is expanding clinically and geographically, with launches in Ohio and plans for more states, achieving early wins like 26% pain reduction and 69% drop in pain-related admissions from piloted tech.[1][2][3]
Tuesday Health emerged in 2023 from a strategic partnership between Valtruis and Mass General Brigham Ventures, driven by a mission to modernize supportive care for seriously ill patients using clinical know-how and tech.[1][2][3][4] CEO Jim Wieland, former president of Magellan Specialty Health (sold to Centene and Evolent), leads with deep healthcare operations experience, while Dr. Mihir Kamdar, head of care delivery and ex-section head of palliative care at Mass General Brigham, brings frontline expertise in symptom management.[1][2][3] The idea stemmed from Mass General's pilot of the mytuesday app for oncology pain, yielding strong results, prompting the hybrid model to engage patients earlier in disease progression for proactive interventions.[2][3]
Early traction included the $60 million raise to build clinical infrastructure, hire teams, enhance the app for remote monitoring, and go live in markets like Ohio by mid-2024.[3]
Tuesday Health rides the value-based care wave in aging populations and rising chronic illness costs, where supportive/palliative care gaps drive unnecessary hospitalizations—addressed via digital tools modernizing fragmented end-of-life services.[2][3][4] Timing aligns with Medicare risk-bearing expansions (Shared Savings, Advantage plans) favoring proactive models, amplified by post-pandemic telehealth adoption and AI/data for remote monitoring.[1][2][5] Market tailwinds include investor interest in healthtech reducing acute care spend; Tuesday influences the ecosystem by partnering with incumbents like CareSource, scaling evidence-based tech (e.g., ePAL trial), and proving ROI for payers.[1][3][7]
Tuesday Health is poised to scale nationally post-Ohio launch, prioritizing tech upgrades, clinician hires, and multi-state expansion to capture share in the $100B+ supportive care market.[3] Trends like AI-driven personalization, payer shifts to risk models, and hospice integration will propel growth, potentially evolving it into a platform leader influencing payer-provider dynamics. As a 2023 entrant with proven pilots and heavyweight backers, its momentum positions it to redefine serious illness care—transforming "Tuesday" from ordinary to a symbol of timely, tech-empowered support.[1][2][4]
Tuesday Health has raised $60.0M in total across 1 funding round.
Tuesday Health's investors include BlueCross BlueShield Venture Partners, David Caluori.
